Catalog

Modified C-terminal fragment of human growth hormone (HGH 177-191) synthesized for lipid metabolism and lipolysis research without glycemic alterations.

Non-erythropoietic peptide derived from the helix B domain of erythropoietin engineered for innate repair receptor (IRR) signaling and tissue cytoprotection studies.

High-purity aqueous Vitamin B7 reference standard formulated for enzymatic carboxylase cofactor assays and cellular metabolism investigations.

Synthetic 15-amino acid Body Protection Compound fragment formulated for angiogenic signaling, tendon fibroblast, and cytoprotection research.

Encapsulated gastrostable BPC-157 formulation designed for non-invasive in vitro digestion models and gastrointestinal mucosal pathway evaluation.

Long-acting synthetic amylin analog engineered for calcitonin/amylin receptor activation and central satiety signal transduction studies.

Bioregulator tripeptide (Ala-Glu-Asp) developed for chondrocyte gene expression, extracellular matrix homeostasis, and cartilage longevity research.

Modified growth hormone releasing hormone fragment (GHRH 1-29 / Mod GRF 1-29) synthesized for physiological, pulsatile pituitary GH release kinetics.

Long-acting GHRH analog conjugated with Drug Affinity Complex (DAC) designed for extended bioconjugation to endogenous serum albumin.

Oligopeptide hepatocyte growth factor (HGF/c-Met) pathway agonist encapsulated for synaptogenesis, dendritic spine density, and neuroplasticity studies.

Endogenous Delta Sleep-Inducing Peptide nonapeptide formulated for slow-wave sleep architecture, circadian rhythm, and neuromodulatory analysis.

Pineal-derived tetrapeptide (Ala-Glu-Asp-Gly) synthesized for telomerase catalytic subunit (hTERT) activation and cellular senescence assays.

Retro-inverso D-amino acid peptide engineered to disrupt the FOXO4-p53 interaction, selectively triggering apoptosis in senescent cells.

High-affinity copper(II) chelated tripeptide (glycyl-L-histidyl-L-lysine-Cu) synthesized for collagen synthesis, gene expression, and tissue remodeling research.

Reduced master endogenous antioxidant tripeptide (gamma-L-glutamyl-L-cysteinylglycine) prepared for cellular redox potential and detoxification assays.

Synthetic decapeptide identical to endogenous gonadotropin-releasing hormone (GnRH) for pituitary gonadotrope LH and FSH secretagogue studies.

High-affinity GLP-1 receptor agonist peptide engineered for insulinotropic signaling, gastric motility, and metabolic homeostasis research.

Dual-agonist peptide targeting both GLP-1 and GIP receptors for synchronized incretin signaling and energy expenditure modeling.

Next-generation tri-agonist peptide addressing GLP-1, GIP, and Glucagon receptors for comprehensive thermogenic and metabolic pathway research.

Purified Human Chorionic Gonadotropin glycoprotein formulated for luteinizing hormone receptor (LHCGR) signaling and steroidogenic pathway investigations.

Recombinant 191-amino acid Human Growth Hormone identical to pituitary somatotropin for somatotropic axis and cellular proliferation assays.

Long-acting recombinant insulin-like growth factor-1 analog with Arg3 substitution and 13-amino acid N-terminal extension for minimal IGFBP binding.

Highly selective pentapeptide growth hormone secretagogue (GHS) that activates the ghrelin receptor without off-target cortisol or prolactin release.

Metastin-derived neuroendocrine peptide (Kisspeptin-10) formulated for GPR54 (KISS1R) receptor activation and upstream HPG axis signaling.

C-terminal tripeptide fragment of alpha-MSH (Lys-Pro-Val) formulated for selective anti-inflammatory and NF-kB transcriptional inhibition studies.

Encapsulated oral formulation of KPV tripeptide prepared for gastrointestinal barrier, gut microbiome, and enteric inflammatory response modeling.

L-carnitine amino acid derivative formulated for carnitine palmitoyltransferase (CPT-1) mitochondrial fatty acid transport studies.

Sterile liquid solution containing methionine, inositol, choline, and carnitine formulated for hepatic lipid mobilization research.

Enhanced lipotropic liquid solution enriched with B-complex vitamins for co-enzymatic cellular energy and methylation profiling.

Bioactive coenzyme form of Vitamin B12 in sterile liquid format formulated for methionine synthase and neurological methylation assays.

Mitochondrial-derived 16-amino acid peptide that regulates metabolic homeostasis through AMPK activation and cellular folate-methionine cycling.

Cyclic lactam analog of alpha-MSH designed for non-selective melanocortin receptor (MC1R-MC5R) signaling and melanogenesis investigations.

Intranasal delivery formulation of NAD+ formulated for olfactory-transmucosal brain delivery and central sirtuin activation studies.

Pure Nicotinamide Adenine Dinucleotide coenzyme prepared for sirtuin (SIRT1-SIRT7) and PARP-mediated DNA repair kinetic assays.

Endogenous neurohypophysial nonapeptide prepared for oxytocin receptor (OXTR) neurobiology and social cognition signaling studies.

Intranasal oxytocin solution developed for direct CNS receptor engagement and behavioral neurocircuitry investigations.

PEGylated Mechano-Growth Factor (IGF-1Ec fragment) engineered for extended half-life and muscle satellite cell activation research.

Neuroprotective short bioregulator tripeptide (Glu-Arg-Asp) designed for brain gene expression and neuronal survival assays.

Prostate-specific bioregulator tripeptide (Lys-Glu-Asp) developed for prostatic cell differentiation and tissue homeostasis research.

Synthetic cyclic peptide analog of alpha-MSH (Bremelanotide) targeting MC3R and MC4R for central sexual signaling research.

Intranasal Bremelanotide (PT-141) formulation designed for non-invasive delivery and central melanocortin receptor pharmacokinetics.

Heptapeptide analog of human Tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro) formulated for allosteric GABA-A modulation and BDNF expression research.

Intranasal Selank solution calibrated for rapid mucosal olfactory absorption and central neurocognitive studies.

Synthetic heptapeptide analog of ACTH(4-10) developed for neuroprotection, NGF/BDNF upregulation, and cerebral ischemia research.

Intranasal Semax mist formulation designed for rapid trans-cribriform cerebral uptake and cognitive neuroprotection modeling.

Truncated 29-amino acid functional fragment of GHRH (GRF 1-29 amide) formulated for pituitary somatotropic GH stimulation kinetics.

Mitochondria-targeting tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) engineered to selectively bind cardiolipin and restore electron transport chain efficiency.

Synergistic research stack combining AOD-9604, CJC-1295 (No DAC), and Ipamorelin for multi-pathway growth hormone secretagogue and lipolytic kinetic investigation.

Dual-peptide matrix combining BPC-157 and TB-500 (Thymosin Beta-4 fragment) to study concurrent actin filament regulation and vascular endothelial migration.

Triple-action investigative peptide stack providing concurrent angiogenic (BPC-157), actin-sequestration (TB-500), and anti-inflammatory alpha-MSH (KPV) signaling pathways.

Dual GH secretagogue stack pairing GHRH-analog CJC-1295 No DAC with selective ghrelin-receptor agonist Ipamorelin for amplified somatotrope signal transduction.

Neurotropic peptide synergy combining delta sleep-inducing neuropeptide (DSIP) with anxiolytic melanocortin derivative (Selank) for central stress axis regulation.

Bioregulator longevity stack combining telomerase-inducing Epithalon with chromatin-remodeling copper tripeptide GHK-Cu.

Comprehensive cellular longevity matrix integrating genomic repair (GHK-Cu), telomere maintenance (Epithalon), and mitochondrial AMPK activation (MOTS-c).

Benchmark regenerative triad combining high-dose GHK-Cu (50mg) with BPC-157 (10mg) and TB-500 (10mg) for comprehensive cellular and vascular matrix remodeling.

Advanced multi-receptor stack combining tri-incretin agonist GP3 (R) with long-acting amylin analog Cagrilintide for dual metabolic pathway analysis.

Synergistic quad-peptide master healing stack combining KPV, GHK-Cu, TB-500, and BPC-157 in calibrated multi-dose ratios.

Dual-action intranasal blend pairing Bremelanotide (PT-141) with Oxytocin for combined central melanocortin and oxytocinergic pathway modeling.

Triple neuro-modulatory peptide triad combining neurotrophic Semax (10mg), anxiolytic Selank (10mg), and sleep-regulating DSIP (2mg).

Synergistic GH pulse matrix pairing long-acting GHRH agonist Tesamorelin with selective ghrelin receptor agonist Ipamorelin.

Tri-pathway metabolic enhancement stack integrating Tesamorelin (10mg), Ipamorelin (5mg), and mitochondrial peptide MOTS-c (10mg).

Triple host-defense peptide complex combining Thymosin Alpha-1 (10mg), KPV (10mg), and cathelicidin antimicrobial peptide LL-37 (5mg).

Immunomodulatory dual peptide stack pairing immune-stimulatory Thymosin Alpha-1 (10mg) with NF-kB inhibitory KPV (10mg).

Synthetic bioactive domain of Thymosin Beta-4 (Ac-LKKTETQ) developed for actin cytoskeleton regulation and cell migration assays.

Triple monoamine reuptake inhibitor (SNDRI) encapsulated for central appetite regulation, dopamine-noradrenaline transport, and metabolic studies.

Stabilized hexenoyl-conjugated GHRH analog (1-44 amide) formulated for visceral adipose lipolysis and pituitary GH secretion modeling.

Thymic peptide (28 amino acids) synthesized for toll-like receptor (TLR9) signaling, T-cell maturation, and immune response research.